person reading

About Apogee Therapeutics Inc. - Company Information, Overview, History and Profile

What does Apogee Therapeutics Inc. do?

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Apogee Therapeutics Inc. Management structure

All Gross Remunerations are in USD
Ms. Jane Pritchett Henderson
Chief Financial Officer and Chief Accounting Officer
-
2024
Gross Remuneration
Year
Dr. Michael Henderson, M.D.
Chief Executive Officer and Director
-
2024
Gross Remuneration
Year

Apogee Therapeutics Inc. Board of directors

All Gross Remunerations are in USD
Dr. Lisa L. Bollinger, M.D.
Director
-
2024
Gross Remuneration
Year
Mr. William B.J. Jones, Jr
Independent Director
-
2024
Gross Remuneration
Year
Mr. Mark C. McKenna
Chairman of the Board
-
2024
Gross Remuneration
Year
Dr. Michael Henderson, M.D.
Chief Executive Officer and Director
-
2024
Gross Remuneration
Year
Mr. Peter Harwin
Independent Director
-
2024
Gross Remuneration
Year
Mr. Tomas Kiselak
Independent Director
-
2024
Gross Remuneration
Year